Skip to main content

Roche to found Institute for Human Biology

| News

Roche to found Institute for Human Biology

04.05.2023

Roche has announced that it will be establishing the Institute of Human Biology in Basel. Up to 250 employees will be tasked with promoting the broad application of human model systems in pharmaceutical research and clinical practice.

Roche global headquarters in Basel (image: Roche)

The pharma group Roche is establishing an Institute of Human Biology (IHB) in Basel. In conjunction with a satellite laboratory in Schlieren in the canton of Zurich, scientists and bioengineers will in future carry out research there on living 2D or 3D miniature replicas of human tissue and organs, which are more commonly referred to as organoids.

These human models are created on the basis of human stem cells. According to a press release issued by Roche, in this way the dependency on animal testing could be reduced. Moreover, human model systems could potentially facilitate the discovery of new human biology and the identification of drug targets that would otherwise be impossible using classical discovery methods.

“Human model systems such as organoids are the future of our industry”, explains Prof. Dr. Hans Clevers, Head of Pharma Research and Early Development (pRED) at Roche and a pioneer in the field of organoids. These could potentially help to develop more effective and safer medicines that could, in turn, be made available to patients more quickly.

Researchers with great scientific freedom

The number of employees is set to rise to around 250 over the next four years. According to Roche, the researchers have the opportunity to pursue basic research activities with “great scientific freedom”. The insights gained will not only benefit the Group, but in many cases will also be made available to the broader scientific community and regulatory authorities.

“The work at the IHB has the potential to redefine how we discover and develop medicines over the next decade”, comments Dr. Matthias Lutolf, Head IHB at Roche, in the press release. “The institute is uniquely positioned in bringing together biology, bioengineering and data science around human model systems and applying them to real-world challenges in drug discovery and research”, he concludes.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.